#discgenics Archives - Orthopedics This Week

Legal & Regulatory and Reimbursement

Cell Therapy for DDD Advances to Phase III

by Kim DelMonico July 26, 2024November 1, 2024

Spine

New Evidence Supports Viable Cell Spine Treatment

by Elizabeth Hofheinz, M.P.H., M.Ed. March 24, 2023October 24, 2024

Jeff Poole Appointed First Chief Financial Officer of DiscGenics

by Adam Suhy, Ph.D. September 29, 2020November 1, 2024

Spine

DiscGenics: 1st Patient in Cell Treatment for DDD Trial

by Elizabeth Hofheinz, M.P.H., M.Ed. May 23, 2018November 1, 2024